Bristol-Myers Squibb Co. (BMY)
The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.
Recs
Drugs will enhance our quality of life and they are just now getting started. BMY has a good portfolio and management is focused on enhancing revenues for future growth. Great dividend also. What's not to like?
Recs
Strong dividend, strong earnings. This one adds some safety to my real life aggressive portfolio
Recs
Fat yield.
Recs
BMY is a solid company with a great dividend. People will be looking for such a stable company to balance their portfolios. I don't think Obama's health care plan will hurt it either.
Recs
good time to buy - good dividend @ 5.5% - real potential for takeover in near furure-eh
Recs
positive independent ratings. best drug manufacturer. S&P 5 stars. 5.5% div. historically low PE of 13 x's trailing EPS.
Recs
Abilify for adjunctive treatment of depression has been a huge success and patients are reporting results within 1-2 weeks which is unprecedented for an antidepressant (unless it's placebo effect). Analysts are aware of the potential here, but I think the next set of earnings will beat.
Recs
Momentum / defensive pick
Recs
P/E is not overly high. There's a good dividend and they have enough cash on hand to completely cover their LT debt.
Recs
Leading Pharma
Recs
Quality Med Related company, Bargain price, Great Dividend history. I like my chances.
Recs
Passws the Geraldine Weiss criteria as of Sep 6, 2009
Recs
High dividend yield, Underpriced. Low risk and steady growth
Recs
Drug company that produces everyday items. Enough said.
Recs
Another addition to my pharma collection
Recs
Best drugs I ever had
Recs
Ford Strong Buy, S&P (4 or 3 stars), Member of S&P 500
Recs
after all, who doesn't get sick
Recs
With the purchase of Mederex, BMY has significantly strengthened its cancer treatment pipeline. Stock price is pretty cheap, and is a low risk holding with a nice dividend.
Recs
Solid company with bright future, strong R & D. Has more positives than negatives.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 199 1 2 3 4 5 6 7 8 9 10 Next »